Use of Natural Language Processing to identify Obsessive Compulsive Symptoms in patients with schizophrenia, schizoaffective disorder or bipolar disorder

Chandran, D., Robbins, D.A., Chang, C.K., Shetty, H., Sanyal, J., Downs, J., Fok, M., Ball, M., Jackson, R., Stewart, R., Cohen, R., Vermeulen, J.M., Schirmbeck, F., De Haan, L. & Hayes, R.
Verschenen in Scientific Reports, 9, 14146, 1-7 (2019)

Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1-12.5 Years

Vermeulen, J.M., van Rooijen, G., van de Kerkhof, M.P.J., Sutterland, A.L., Correll, C.U. & De Haan, L.
Verschenen in Schizophrenia Bulletin, Volume 45, Issue 2, 315-329 (2019)

Cognitive behavioral therapy for social activation in recent-onset psychosis: Randomized controlled trial

Pos, K., Franke, N., Smit, F., Wijnen, B.F.M., Staring, A.B.P., van der Gaag, M., Meijer, C., De Haan, L., Velthorst, E. & Schirmbeck, F.
Verschenen in Journal of Consulting and Clinical Psychology, 87 (2), 151–160 (2019)

Increased serum levels of leptin and insulin in both schizophrenia and major depressive disorder: A cross-disorder proteomics analysis

Cakici, N., Bot, M., Lamers, F., Janssen, T., van der Spek, P.J., De Haan, L., Bahn, S., Penninx, B.W.J.H. & van Beveren, N.J.M.
Verschenen in European Neuropsychopharmacology, Volume 29, Issue 7, 835-846 (2019)

Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people

Alqarni, A., Todd, W.M., McGorry, P.D., Nelson, B., Markulevm C., Yuen, H.P., Schäfer, M.R., De Haan, L., Meyera, B.J. & et. al.
Verschenen in Schizophrenia Research, Volume 226, 44-51 (2019)

Individualized Prediction of Transition to Psychosis in 1,676 Individuals at Clinical High Risk: Development and Validation of a Multivariable Prediction Model Based on Individual Patient Data Meta-Analysis

Malda, A., Boonstra, N., Barf, H., de Jong, S., Aleman, A., Addington, J., De Haan, L., Pijnenborg, G.H.M. & et al.
Verschenen in Frontiers in Psychiatry, 10, 345 (2019)

Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis

Wijnen, B.F.M., Thielen, F.W., Konings, S., Feenstra, T., van der Gaag, M., Veling, W., De Haan, L., Ising, H., Hiligsman, M., Evers, S.M.A.A., Smit, F. & Lokkerbol, J.
Verschenen in Expert Review of Pharmacoeconomics & Outcomes Research, Volume 20, 2020, Issue 3, 269-279 (2019)

Smoking and the risk for bipolar disorder: evidence from a bidirectional Mendelian randomisation study

Vermeulen, J.M., Wootton, R.E., Treur, J.L., Sallis, H.M., Jones, H.J., Zammit, S., van den Brink, W., Goodwin, G.M., De Haan, L. & Munafo, M.R.
Verschenen in The British Journal of Psychiatry, Volume 218 , Issue 2, 88 - 94 (2019)

Driving us mad: the association of Toxoplasma gondii with suicide attempts and traffic accidents – a systematic review and meta-analysis

Sutterland, A.L., Kuin, A., Kuiper, B., van Gool, T., Leboyer, M., Fond, G. & De Haan, L.
Verschenen in Psychological Medicine, Volume 49, Issue 10 , 1608-1623 (2019)

Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling

van Rooijen, G., van Rooijen, M., Maat, A., Vermeulen, J.M., Meijer, C.J., Ruhé, H.G., De Haan, L. & GROUP Investigators
Verschenen in Schizophrenia Researh, 208, 82-89 (2019)

Measuring process indicators and adverse events to assess the quality of care for inpatients with psychosis

Vermeulen, J.M., van Rooijen, G., van Tricht, M.J., van Dijk, M. & De Haan, L.
Verschenen in Journal of Mental Health, Volume 30, Issue 5, 564-570 (2019)

Obsessive-compulsive symptoms in psychotic disorders: longitudinal associations of symptom clusters on between- and within-subject levels

Schirmbeck, F., Konijn, M., Hoetjes, V., Zink, M. & De Haan, L.
Verschenen in European Archives of Psychiatry and Clinical Neuroscience, 269, 245-255 (2019)

Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study

Guloksuz, S., Pries, L.K., Delespaul, P., Kenis, G., Luykx, J.J., Lin, B.D., De Haan, L., GROUP Researchers & van Os, J.
Verschenen in World Psychiatry, 18(2), 173-182 (2019)

Exploring construct validity of clinical staging in schizophrenia spectrum disorders in an acute psychiatric ward

Berendsen, S., van der Paardt, J., van Bruggen, M., Nusselder, H., Jalink, M., Peen, J., Van, H., Dekker, J.J.M. & De Haan, L.
Verschenen in Clinical Schizophrenia & Related Psychoses (2018)

Patterns of obsessive-compulsive symptoms and social functioning in schizophrenia; a replication study

Swets, M., van Dijk, F.A., Schirmbeck, F., Peen, J., De Haan, L., Alizadeh, B.Z. & van Winkel, R.
Verschenen in Psychiatry Research, 271, 421-427 (2018)

Validity of police contacts as a performance indicator for the public mental health care system in Amsterdam: an open cohort study

Lauriks, S., Buster, M.C.A., de Wit, M.A.S., Arah, O.A., Hoogendoorn, A.W., Peen, J. & Klazinga, N.S.
Verschenen in Social Psychiatry and Psychiatric Epidemiology, 53, 577–586 (2018)

Advanced Glycation End Products in Recent-Onset Psychosis Indicate Early Onset of Cardiovascular Risk

Hagen, J., Sutterland, A.L., Koeter, M.W.J., Lutter, R., Cohn, D.M. & De Haan, L.
Verschenen in The Journal of Clinical Psychiatry (2017)
ISO 9001 HKZNEN7510 Keurmerk

Disclaimer | Privacyverklaring | Cookiebeleid | © 2024 Arkin Onderzoek - Alle rechten voorbehouden | Realisatie: Lemon